CAPTRUST FINANCIAL ADVISORS United Therapeutics Corporation Transaction History

CAPTRUST FINANCIAL ADVISORS portfolio value:

$35.04M
portfolio value

CAPTRUST FINANCIAL ADVISORS quarter portfolio value change:

-11.14%
quarter

United Therapeutics Corporation 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +19.63% 27.46K shares 2.07M $209.38 167.39K
Q2 2022 share Increase +560.33% 118.73K shares 29.16M $235.64 139.92K
Q1 2022 share Decrease -0.72% -153 shares -810K $179.41 21.19K
Q4 2021 share Increase +41.80% 6.29K shares 1.83M $215.18 21.34K
Q3 2021 share Increase +381.48% 11.92K shares 2.21M $184.58 15.05K
Q2 2021 share Increase +1.26% 39 shares 45K $179.41 3.12K
Q1 2021 share Increase +39.75% 878 shares 181K $167.27 3.08K
Q4 2020 share Increase +25.23% 445 shares 153K $151.79 2.20K
Q3 2020 share Decrease -32.77% -860 shares -136K $101 1.76K
Q2 2020 share 0.00% 0 shares 72K $121 2.62K
Q1 2020 share 0.00% 0 shares 16K $94.83 2.62K
Q4 2019 share Increase 0.00% 2.62K shares 230K $88.08 2.62K
Q1 2019 share Decrease -100.00% -257 shares -28K $117.37 0
Q4 2018 share Increase +384.91% 204 shares 21K $108.9 257
Q3 2018 share Increase 0.00% 53 shares 7K $127.88 53